ACTIVE

Farmajes

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result4 k €-86,7 %over 1 year
Gross margin235 k €-3,4 %over 1 year
Equity86 k €0,0 %over 1 year
Workforce2,3 ETP+9,5 %over 1 year

Identity

Source · BCE/KBO

Farmajes is a Private limited company incorporated in 2017. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Antwerpen. It employs on average 2,3 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0681.788.254
Incorporation
26/09/2017
Legal form
Private limited company
Registered office
Lange Koepoortstraat 1
2000 Antwerpen · FlandreSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2025
Average workforce
2,3 ETP
Joint committees (1)
  • 313
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 8 filings

Trend over 8 financial years

20252024202320222021
Income statement
Gross margin235 k €243,1 k €295,2 k €147,3 k €20,6 k €
EBITDA74,1 k €100,9 k €208,2 k €130,2 k €3,2 k €
Operating result21 k €48,6 k €157,8 k €83 k €-18,2 k €
Net result4 k €30,3 k €139,7 k €67,6 k €-24,9 k €
Balance sheet
Equity86 k €86 k €86 k €75,2 k €50,1 k €
Total assets1,3 M €1,4 M €1,4 M €1,4 M €1,2 M €
Cash60,6 k €51,5 k €53,4 k €69,4 k €68,3 k €
Debts1,2 M €1,3 M €1,3 M €1,3 M €1,2 M €
Other
Workforce2,3 ETP2,1 ETP1,5 ETP0,4 ETP–

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 5 ended

Active mandates

ANTWERP PHARMACIES

Director · since 01 janvier 2020 · 0700.733.344

Represented by Jeff Roskams

Active

Ended mandates

Jeff Roskams

Manager · since 26 septembre 2017

Ended
Marie Van den Broeck

Manager · since 26 septembre 2017

Ended
ANTWERP PHARMACIES

Director · 0700.733.344

Represented by Joris Mees

Ended
ANTWERP PHARMACIES

Director · 0700.733.344

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date23/06/202623/06/202501/07/202405/07/202314/07/202218/06/2021
General meeting19/06/202620/06/202521/06/202416/06/202317/06/202218/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 8 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202519/06/202623/06/2026DutchPDF
Abridged model31/12/202420/06/202523/06/2025DutchPDF
Abridged model31/12/202321/06/202401/07/2024DutchPDF
Abridged model31/12/202216/06/202305/07/2023DutchPDF
Abridged model31/12/202117/06/202214/07/2022DutchPDF
Abridged model31/12/202018/06/202118/06/2021DutchPDF
Abridged model31/12/201919/06/202008/07/2020DutchPDF
Micro model31/12/201821/06/201925/07/2019DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 5 ended

Active mandates

ANTWERP PHARMACIES

Director · since 01 janvier 2020 · 0700.733.344

Represented by Jeff Roskams

Active

Ended mandates

Jeff Roskams

Manager · since 26 septembre 2017

Ended
Marie Van den Broeck

Manager · since 26 septembre 2017

Ended
ANTWERP PHARMACIES

Director · 0700.733.344

Represented by Joris Mees

Ended
ANTWERP PHARMACIES

Director · 0700.733.344

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Registered office12/07/2022
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Other10/09/2021
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM
    PDF
  • Mandates25/06/2020
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates04/11/2019
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office19/09/2019
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Other28/09/2017
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 20254 k €↓
  2. 2024
    Annual accounts 202430,3 k €↓
  3. 2023
    Annual accounts 2023139,7 k €↑
  4. 2022
    Annual accounts 202267,6 k €↑
  5. 2021
    Annual accounts 2021-24,9 k €↓
  6. 2020
    Annual accounts 2020127,8 k €↑
  7. 2019
    Annual accounts 2019107,6 k €↑
  8. 2018
    Annual accounts 2018-51,5 k €
  9. 26/09/2017
    IncorporationPrivate limited company